Bill Gates On Vaccine Distribution Challenges, Overcoming Vaccine Hesitancy
The public health advocate and billionaire philanthropist raised issues about how a mass COVID-19 vaccination effort is being handled so far in the US, speaking at the Stat Summit.
You may also be interested in...
Pfizer is moving swiftly towards an emergency use approval filing, with Moderna not far behind.
The company's Phase III COVID-19 vaccine trial has reached the needed safety data required for filing an emergency use authorization with the FDA, Bourla confirmed at the Stat Summit.
Resilience has raised $800m to develop new technologies to manufacture complex drugs including vaccines, cell therapies and gene therapies.